黄芪多糖, ＞70%

2-(CHLOROMETHYL)-4-(4-NITROPHENYL)-1,3-THIAZOLE

Ph-PEG3, 98%

Ph-PEG3

2-(2,6,7,8-四氢-1H-茚并[5,4-b]呋喃-8-基)乙胺盐酸盐, 98%

2-(2,6,7,8-Tetrahydro-1H-indeno[5,4-b]furan-8-yl)ethanamine hydrochloride

AMD3465 hexahydrobromide, 99.9%

AMD3465 hexahydrobromide

JNJ-40411813, ≥99.9%

JNJ-40411813

6-氨基-3,4-二氢喹啉-1（2H）-羧酸甲酯

methyl 6-amino-3,4-dihydroquinoline-1(2H)-carboxylate

三苯甲基依贝沙坦, 98%

2-Butyl-3-((2'-(2-trityl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1,3-diazaspiro[4.4]non-1-en-4-one

环己烷羰基异硫氰酸酯

cyclohexanecarbonyl isothiocyanate

帕拉米松乙酸酯, 99%

Paramethasone Acetate

AZD-6738, GR

AZD-6738

N2,N2-Dimethylguanosine , ≥99.9%

N2,N2-Dimethylguanosine 

Abz-FRK（Dnp）-P

Abz-FRK(Dnp)-P

2-{[（（4-溴苯基）磺酰基]氨基}-3-苯基丙酸

2-([(4-BROMOPHENYL)SULFONYL]AMINO)-3-PHENYLPROPANOIC ACID

Org 27569, ≥99%

Org 27569

喹啉-4-甲酰肼, 98%

Quinoline-4-carbohydrazide

LDK378, ≥99.9%

LDK378

N-(2,6-二甲基苯基)-2-(4-(2-羟基-3-(2-甲氧基苯氧基)-丙基)哌嗪-1-基)乙酰胺 二盐酸盐, > 99 % HPLC, solid

RANOLAZINE DIHYDROCHLORIDE

2-氯-5-(2H-四唑-5-基)-4-((噻吩-2-基甲基)氨基)苯磺酰胺, 98%

2-Chloro-5-(2H-tetrazol-5-yl)-4-((thiophen-2-ylmethyl)amino)benzenesulfonamide

2-氨基-3-氰基-7-二甲基氨基-4-(3-三氟甲基苯基)-4H 苯并吡喃, ≥99% (HPLC), solid

Chromeceptin

STAT3抑制剂VII

STAT3 Inhibitor VII

≥98%